Methicillin-resistant Staphylococcus aureus and Vancomycin Prescribing in the Emergency Department: A Single-center

Joshua D Niforatos1, Jeremiah S Hinson1, Richard E Rothman1

  • 1Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Abstract

Insights

Vancomycin use in the emergency department (ED) is common, but MRSA bacteremia is infrequent. Many patients with MRSA did not receive appropriate antimicrobials, and MRSA risk factors were not predictive.

Area of Science:

  • Infectious Diseases
  • Antimicrobial Stewardship
  • Emergency Medicine

Background:

  • The 2021 Surviving Sepsis Campaign Guidelines support methicillin-resistant Staphylococcus aureus (MRSA) antimicrobial stewardship.
  • Vancomycin is frequently administered in the emergency department (ED).

Purpose of the Study:

  • To assess vancomycin utilization in the ED prior to the 2021 guidelines.
  • To evaluate the proportion of patients with MRSA-positive cultures receiving vancomycin.
  • To identify clinical factors associated with MRSA infection.

Main Methods:

  • Retrospective cohort study of adult patients receiving IV vancomycin in 5 EDs.
  • Assessed MRSA-positive blood cultures and MRSA risk factors.
  • Analyzed associations between clinical attributes and MRSA infection.

Main Results:

  • Of 20,212 ED visits with vancomycin, 63% had MRSA risk factors.
  • Only 2.4% had MRSA bacteremia and 14.1% had any MRSA-positive culture.
  • Many patients with culture-proven MRSA (63.8% bacteremia, 43.4% any culture) did not receive MRSA-specific antimicrobials in the ED.
  • MRSA risk factors were not associated with MRSA bacteremia or positive cultures.

Conclusions:

  • MRSA is an infrequent cause of bacteremia in ED sepsis/septic shock patients.
  • Vancomycin is overused in the ED, and appropriate MRSA antimicrobials are underutilized.
  • Lack of predictive value for MRSA risk factors complicates ED antimicrobial stewardship.